Combined oropharyngeal/nasal swab is equivalent to nasopharyngeal sampling for SARS-CoV-2 diagnostic PCR
Authors:
- Tania DesmetTDTania Desmet
- Peter De PaepePPPeter De Paepe
- Jerina BoelensJBJerina Boelens
- Liselotte CoorevitsLCLiselotte Coorevits
- Elizaveta PadalkoEPElizaveta Padalko
- Stien VandendriesscheSVStien Vandendriessche
- Isabel Leroux-RoelsILIsabel Leroux-Roels
- Annelies AerssensAAAnnelies Aerssens
- Steven CallensSCSteven Callens
- Eva Van BraeckelEBEva Van Braeckel
- Thomas MalfaitTMThomas Malfait
- Frank VermassenFVFrank Vermassen
Preprint
Abstract
Background: Early 2020, a COVID-19 epidemic became a public health emergency of international concern. To address this pandemic broad testing with an easy, comfortable and reliable testing method is of utmost concern. The nasopharyngeal (NP) swab sampling is the reference method though hampered by international supply shortages. A new oropharyngeal/nasal (OP/N) sampling method was investigated using the more readily available throat swab. Methods: In this prospective observational study 36 COVID-19 patients were tested with both a NP and combined OP/N swab for SARS-CoV-2 RNA by PCR. In hospitalized suspect patients, who tested negative on both swabs, extensive retesting was performed. The sensitivity of NP versus combined OP/N swab sampling on admission and the correlation between viral RNA loads recovered was investigated. Results: 35 patients were diagnosed with SARS-CoV-2 by means of either NP or OP/N sampling. The paired swabs were both positive in 31 patients. The one patient who tested negative on both NP and OP/N swab on admission, was ultimately diagnosed on bronchoalveolar lavage fluid. A strong correlation was found between the viral RNA loads of the paired swabs (r = 0.76; P < 0.05). The sensitivity of NP and OP/N analysis in hospitalized patients (n = 28) was 89.3% and 92.7% respectively. Conclusions: This study demonstrates equivalence of NP and OP/N sampling for detection of SARS-CoV-2 by means of rRT-PCR. Sensitivity of both NP and OP/N sampling is very high in hospitalized patients.Keywords
All Related Versions
- Published version: BMC Microbiology, 21 (1), 1.
This publication has 9 references indexed in Scilit:
- Saliva is a reliable tool to detect SARS-CoV-2Journal of Infection, 2020
- Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus 2Annals of Internal Medicine, 2020
- Nasal Swab Sampling for SARS-CoV-2: a Convenient Alternative in Times of Nasopharyngeal Swab ShortageJournal of Clinical Microbiology, 2020
- Comparison of Copan ESwab and FLOQSwab for COVID-19 Diagnosis: Working around a Supply ShortageJournal of Clinical Microbiology, 2020
- Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneouslyInternational Journal of Infectious Diseases, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Detection of SARS-CoV-2 in Different Types of Clinical SpecimensJAMA, 2020
- Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2) infected pneumonia (COVID-19)medRxiv, 2020
- Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infectionsmedRxiv, 2020